Changes in the serum proteome of patients with sepsis and septic shock

Anesthesia and Analgesia

Volumn 103, Issue 6, 2006, Pages 1522-1526

  Kalenka, Armin ^a   Feldmann Jr , Robert E ^a   Otero, Kevin ^a   Maurer, Martin H ^a   Waschke, Klaus F ^a   Fiedler, Fritz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; PROTEOME;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; FATALITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; SEPSIS; SEPTIC SHOCK; SERUM; SURVIVAL; SURVIVOR; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; BLOOD PROTEINS; CLUSTERIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; SEPSIS; SHOCK, SEPTIC;

EID: 33845607659     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000242533.59457.70     Document Type: Article

References (21)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
2. Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 2003;124:1103-15.
3. Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans. Nature 2005;437:1032-7.
4. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-7.
5. Haynes P, Gygi S, Figeys D, Aebersold R. Proteome analysis: biological assay or data archive? Electrophoresis 1998;19:1862-71.
6. Anderson N, Anderson N. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-67.
7. Björhall K, Miliotis T, Davidsson P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005;5:307-17.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
9. Choe L, Lee K. Quantitative and qualitative measure of intralaboratory two-dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysis. Electrophoresis 2003;24:3500-7.
10. Perkins D, Pappin D, Creasy D, Cottrell J. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-67.
11. Hall RE, Blaese RM, Davis AE III, et al. Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes. J Exp Med 1982;156:834-43.
12. Sundsmo J, Gotze O. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading. J Exp Med 1984;154:763-77.
13. Peters M, Ambrus JJ, Fauci A, Brown E. The Bb fragment of complement factor B acts as a B cell growth factor. J Exp Med 1988;168:1225-35.
14. Dobryszycka W. Biological functions of haptoglobin - new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 1997;35:647-54.
15. Arredouani MS, Kasran A, Vanoirbeek JA, et al. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 2005;114:263-71.
16. Rosenberg M, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;27:633-45.
17. Jones S, Jomary C. Clusterin. Int J Biochem Cell Biol 2002;34:427-31.
18. Viard I, Wehrli P, Jornot L, et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Investig Dermatol 1999;112:290-6.
19. Hogasen K, Mollnes T, Brandtzaeg P. Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex. Infect Immun 1994;62:4874-80.
20. Heller A, Fiedler F, Braun P, et al. Clusterin protects the lung from leukocyte-induced injury. Shock 2003;20:166-70.
21. Granger J, Siddiqui J, Copeland S, Remick D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 2005;5:4713-8.